Literature DB >> 10754218

Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex.

P A Tooney1, G G Au, L A Chahl.   

Abstract

The distribution of tachykinin NK(1) and NK(3) receptors in the prefrontal (Brodmann area 9) and visual cortex (Brodmann area 17) of formalin-fixed postmortem human brain tissue was studied by immunohistochemistry. NK(1)-like immunoreactivity (NK(1)-LI) was observed as a thin band at the cortical surface and dots of NK(1)-LI localised on small non-pyramidal cells and in the neuropil (layers I-III). NK(3)-LI was found in beaded fibres and cells with astrocyte-like morphology in the superficial cortical layers and white matter. Dots of NK(3)-LI were prominent in the neuropil and on pyramidal (layers III/V) and non-pyramidal (layers V/VI) cells. The NK(3)-LI was more abundant and widespread than the NK(1)-LI. This is the first report of the distribution of the NK(1) receptor in the prefrontal and visual cortex of the human brain by immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10754218     DOI: 10.1016/s0304-3940(00)00979-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.

Authors:  P Malherbe; F Knoflach; M C Hernandez; T Hoffmann; P Schnider; R H Porter; J G Wettstein; T M Ballard; W Spooren; L Steward
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 2.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Pharmacokinetics and central nervous system effects of the novel dual NK1 /NK3 receptor antagonist GSK1144814 in alcohol-intoxicated volunteers.

Authors:  Erik T te Beek; Justin L Hay; Jonathan N Bullman; Clare Burgess; Kimberly J Nahon; Erica S Klaassen; Frank A Gray; Joop M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

4.  Of mice and men: bridging the translational disconnect in CNS drug discovery.

Authors:  Hugo Geerts
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

5.  Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions.

Authors:  Jian-Ping Lai; Avital Cnaan; Huaqing Zhao; Steven D Douglas
Journal:  J Neurosci Methods       Date:  2007-10-17       Impact factor: 2.390

Review 6.  The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience.

Authors:  Irina Dedova; Antony Harding; Donna Sheedy; Therese Garrick; Nina Sundqvist; Clare Hunt; Juliette Gillies; Clive G Harper
Journal:  Int J Mol Sci       Date:  2009-01-23       Impact factor: 6.208

7.  Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628.

Authors:  Katarina Varnäs; Sjoerd J Finnema; Vladimir Stepanov; Akihiro Takano; Miklós Tóth; Marie Svedberg; Søren Møller Nielsen; Nikolay A Khanzhin; Karsten Juhl; Benny Bang-Andersen; Christer Halldin; Lars Farde
Journal:  Int J Neuropsychopharmacol       Date:  2016-08-12       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.